# Jean-François Paumelle

> Jean-François Paumelle is a venture - series unknown investor at Alto Invest backing Genetics. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Alto Invest](https://shizune.co/investors/profile/alto-invest)
- Total investments: 1
- Last investment: Mar 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jean-françois-paumelle-38412629

Jean-François Paumelle is a venture - series unknown investor at Alto Invest focused on Genetics and Software. In addition to his activities as CEO of Alto Invest, Jean-François hinge is also Vice President of the Commission of the French Capital Investment Management Association.Before taking the Alto Invest Officer Jean-François hinge previously worked within the AGF Group, where he was co-founder and CEO AGF Private Equity. Previously, it was foundedPower and Deputy Director, responsible for mergers and acquisitions activities of the bank of the Phoenix (AGF), Holder of Power in Corporate Finance in the investment bank Robert Fleming in Paris and London .

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 100% |
| Software | 1 | 100% |
| Analytics | 1 | 100% |
| Bioinformatics | 1 | 100% |
| Data Visualization | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Qlucore | Qlucore (www.qlucore.com) is a leading provider of new generation intuitive bioinformatics software for research and precision and companion diagnostics. Qlucore’s mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. This is done by providing powerfulvisualization-based bioinformatics data analysis tools for research and precision diagnostics. The tools are so easy to use that researchers, technicians and physicians easily can interpret and explore their datasets.The Qlucore Omics Explorer software is a Do-It-Yourself bioinformatics software for research in the life science, plant- and biotech industries, as well as academia. The powerful and flexible visualization-based analysis tool with built-in powerful statistics delivers results instantly. The Qlucore Diagnostics software is a platform for multi-omics companion and precision diagnostics. AI-powered, disease-specific machine learning-based classifier models are combined with patient-friendly visualizations in a an easy to use and cost-effective software solution that integrates with a wide range of data-generating techniques and instruments. Qlucore was founded in 2007 by leading researchers at the Departments of Mathematics and Clinical Genetics at Lund University, Sweden. Today Qlucore has customers in about 35 countries around the world, with sales offices in Europe and North America, and distribution in several countries in Asia. Many of the leading pharmaceutical companies use Qlucore in their research, as well as hospitals and universities around the world.Download a trial version today at www.qlucore.com. | $3.4M | Venture - Series Unknown | Mar 31, 2021 |  |

1 of 1 investments shown.

## About Alto Invest

VC Fund · Versailles, France

ALTO INVEST was founded by partners Antoine Valdes and Jean-François Paumelle, who have worked together since 1994 for one of Europe's largest financial institutions. Their team has managed several portfolios on behalf of institutional and private clients, and made more than 50 private equity investments in Europe, North America and Asia.

5 contacts available at Alto Invest.

| Name | Title | Profile |
| --- | --- | --- |
| Franck Halley | Associate Director | https://shizune.co/investors/profile/franck-halley |
| Jean-François Paumelle | Managing Director | https://shizune.co/investors/profile/jean-franois-paumelle |
| Benoit Thiedey | Head of Investments | https://shizune.co/investors/profile/benoit-thiedey |
| Emilie Da Silva | Head of Investments | https://shizune.co/investors/profile/emilie-da-silva |
| Marie Conilh de Beyssac | Back Office Manager - Partner Relations | https://shizune.co/investors/profile/marie-conilh-de-beyssac |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Jean-François Paumelle invest in?

Jean-François Paumelle invests primarily in Genetics, Software and Analytics startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jean-François Paumelle last invest?

The most recent investment recorded for Jean-François Paumelle closed in Mar 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co